Cushing's Disease in Dogs and Humans

被引:33
作者
de Bruin, C. [1 ]
Meij, B. P. [2 ]
Kooistra, H. S. [2 ]
Hanson, J. M. [2 ]
Lamberts, S. W. J. [1 ]
Hofland, L. J. [1 ]
机构
[1] Erasmus MC, Dept Internal Med, Div Endocrinol, NL-3000 Rotterdam, Netherlands
[2] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands
关键词
Canine; Corticotroph adenoma; Pituitary; Hypercortisolism; Animal model; PITUITARY-DEPENDENT HYPERADRENOCORTICISM; TRANSSPHENOIDAL HYPOPHYSECTOMY; SECRETION; PROLIFERATION; ADENOMAS; SOM230; TUMORS; CELLS;
D O I
10.1159/000178058
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: Cushing's disease (CD) is a common endocrinological disorder in dogs with an estimated incidence of 1 to 2 cases/1,000 dogs/year. This is in contrast to humans in whom CD is rare. The clinical presentation of CD, however, is highly similar between dogs and humans, with characteristic signs, such as abdominal obesity, weight gain, fatigue, muscle atrophy and skin changes. Canine CD may therefore serve as an animal model for human CD, especially since therapeutic canine hypophysectomy can generate substantial amounts of primary corticotroph adenoma tissue for in vitro research purposes. In a recent study, we found that dopamine (DA) D(2) and somatostatin (SS) receptor subtypes are well expressed in canine corticotroph adenomas, but there are some distinct differences compared with the expression profile observed in human CD. These differences need to be considered when using canine CD as a model to evaluate the efficacy of novel DA/SS compounds for potential use in human CD. Case Report: This case involves an 8-year-old female dog that developed signs of exercise intolerance, muscle weakness and polyuria/polydipsia due to an adrenocorticotropic hormone-secreting pituitary adenoma. The dog underwent curative transsphenoidal hypophysectomy and has remained in complete remission in the 3.5 years since surgery. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:140 / 143
页数:4
相关论文
共 17 条
[1]
The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas [J].
Batista, Dalia L. ;
Zhang, Xun ;
Gejman, Roger ;
Ansell, Peter J. ;
Zhou, Yunli ;
Johnson, Sarah A. ;
Swearingen, Brooke ;
Hedley-Whyte, E. Tessa ;
Stratakis, Constantine A. ;
Klibanski, Anne .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4482-4488
[2]
Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease [J].
Bilodeau, Steve ;
Vallette-Kasic, Sophie ;
Gauthier, Yves ;
Figarella-Branger, Dominique ;
Brue, Thierry ;
Berthelet, France ;
Lacroix, Andre ;
Batista, Dalia ;
Stratakis, Constantine ;
Hanson, Jeanette ;
Meij, Bjorn ;
Drouin, Jacques .
GENES & DEVELOPMENT, 2006, 20 (20) :2871-2886
[3]
BOSCARO M, 2006, ENDO 2006 BOST US
[4]
DEBRUIN C, 2008, ENDOCRINOLOGY 0515, DOI DOI 10.1210/EN.2008-0244
[5]
MORBIDITY AND MORTALITY IN CUSHINGS-DISEASE - AN EPIDEMIOLOGIC APPROACH [J].
ETXABE, J ;
VAZQUEZ, JA .
CLINICAL ENDOCRINOLOGY, 1994, 40 (04) :479-484
[6]
Prognostic factors for outcome after transsphenoidal hypophysectomy in dogs with pituitary-dependent hyperadrenocorticism [J].
Hanson, Jeanette M. ;
Teske, Erik ;
Voorhout, George ;
Galac, Sara ;
Kooistra, Hans S. ;
Meij, Bjorn P. .
JOURNAL OF NEUROSURGERY, 2007, 107 (04) :830-840
[7]
Hanson JM, 2005, J VET INTERN MED, V19, P687, DOI 10.1892/0891-6640(2005)19[687:EOTHIT]2.0.CO
[8]
2
[9]
Molecular targets in pituitary tumours [J].
Heaney, AP ;
Melmed, S .
NATURE REVIEWS CANCER, 2004, 4 (04) :285-295
[10]
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5 [J].
Hofland, LJ ;
van der Hoek, J ;
Feelders, R ;
van Aken, MO ;
van Koetsveld, PM ;
Waaijers, M ;
Sprij-Mooij, D ;
Bruns, C ;
Weckbecker, G ;
de Herder, WW ;
Beckers, A ;
Lamberts, SWJ .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (04) :645-654